Rapid Response mRNA Vaccine Facility Gets €30M Funding
An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development…
01/03/2019 - 3 minutes
mRNA: A New Technology Moving into the Mainstream
Messenger RNA (mRNA) technology is based on the idea that human cells can be used as on-demand factories to develop therapeutic proteins by giving them instructions in the form of mRNA. Although mRNA therapeutics and vaccines could be found in drug development pipelines before Covid-19 emerged, the pandemic suddenly moved the mRNA technology into the limelight.
Now, the world has seen mass vaccinations using mRNA-based vaccines developed by Moderna and Pfizer/BioNTech. But the mRNA technology holds promise for other indications as well, including cancer and rare diseases. Read on to learn how this new technology is moving into the mainstream with an influx of investments and new discoveries.
Show More
Editor's Picks for mRNA technology
- Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
- Covid-19 Pandemic Drives RNA Therapeutics into the Mainstream
- EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
- Next-Generation mRNA Vaccine Technology Unveiled in Series A Round
- Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology
European Biotech Industry Report 2021
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations.
Go to ReportLatest mRNA technology Articles
What Does the Largest Biotech IPO Ever Mean for European Biotech?
With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The…
11/12/2018 - 3 minutes
Pfizer Offers €374M for German mRNA Flu Vaccine
BioNTech, based in Mainz, Germany, has entered into a partnership with Pfizer worth up to…
16/08/2018 - 2 minutes
German Biotech Raises Record $270M Series A for Individualized Cancer Therapies
BioNTech will dedicate its huge fundraising to develop personalized cancer immunotherapies using CAR-T, TCR and…
04/01/2018 - 2 minutes
US Biotech Unicorn Steps up Competition for BioNTech’s mRNA Personalized Cancer Vaccine
Moderna Therapeutics has started dosing patients with an mRNA-based personalized cancer vaccine that resembles another…
15/11/2017 - 2 minutes
Battle of the Biotech Unicorns: CureVac vs. Moderna
An interview never seen before. We brought together the founders and CEOs of the two…
06/11/2017 - 4 minutes
AstraZeneca and Moderna want to beat Novartis at Treating Heart Failure
AstraZeneca will work with Moderna Therapeutics to bring together to the market an mRNA version of Novartis' failed…
02/11/2017 - 2 minutes
Eli Lilly Offers German Biotech up to €1.5Bn to Develop mRNA Cancer Vaccines
CureVac will be working with pharma giant Eli Lilly in the development of up to…
18/10/2017 - 3 minutes
These Three Fields Are Proving Biotech is The Innovation Powerhouse in Healthcare
Biotech is the best source of innovation in R&D, making its companies the darlings of…
26/09/2017 - 8 minutes
Belgian Biotech Gets €1M Grant to Boost its mRNA Cancer Immunotherapies
Flanders Innovation and Entrepreneurship has given eTheRNA a €1M grant to further improve its TriMix…
25/09/2017 - 1 minute
RNA as a Therapy: Reviewing the Future Generation of Therapeutics
You’ve certainly heard about antibodies, peptides and even DNA as therapeutics, but what about RNA?…
19/09/2017 - 9 minutes
AstraZeneca Teams Up with German Biotech to Develop mRNA Therapy
AstraZeneca and its R&D arm MedImmune have partnered with Munich-based Ethris to use its mRNA…
21/08/2017 - 2 minutes
